Close Menu

NEW YORK – Waters said in a filing Tuesday with the US Securities and Exchange Commission that it entered a note purchase agreement through which it sold $500 million of senior notes.

The company sold $100 million of senior notes with a fixed interest rate of 1.68 percent and maturing on March 2, 2026, and $400 million of senior notes with a fixed interest rate of 2.25 percent and maturing on March 3, 2031.

Waters said it will use the proceeds of the issuance to repay other outstanding debt and for general corporate purposes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.